These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 23736174)
41. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy. Hodgson KA; Huynh J; Ibrahim LF; Sacks B; Golshevsky D; Layley M; Spagnolo M; Raymundo CM; Bryant PA Arch Dis Child; 2016 Oct; 101(10):886-93. PubMed ID: 27166221 [TBL] [Abstract][Full Text] [Related]
42. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. Mackintosh CL; White HA; Seaton RA J Antimicrob Chemother; 2011 Feb; 66(2):408-15. PubMed ID: 21118914 [TBL] [Abstract][Full Text] [Related]
43. Risk Factors for Complications during Outpatient Parenteral Antimicrobial Therapy for Adult Orthopedic and Neurosurgical Infections. Felder KK; Marshall LM; Vaz LE; Barnes PD South Med J; 2016 Jan; 109(1):53-60. PubMed ID: 26741876 [TBL] [Abstract][Full Text] [Related]
44. Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic. Suleyman G; Kenney R; Zervos MJ; Weinmann A J Clin Pharm Ther; 2017 Feb; 42(1):39-43. PubMed ID: 27747899 [TBL] [Abstract][Full Text] [Related]
45. Risk of venous thromboembolism in patients treated for bacterial infection in the community with outpatient parenteral antimicrobial therapy. Barr DA; Irvine S; Ritchie ND; McCutcheon J; Seaton RA QJM; 2014 Mar; 107(3):207-11. PubMed ID: 24300160 [TBL] [Abstract][Full Text] [Related]
46. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623 [TBL] [Abstract][Full Text] [Related]
47. The history and evolution of outpatient parenteral antibiotic therapy (OPAT). Williams DN; Baker CA; Kind AC; Sannes MR Int J Antimicrob Agents; 2015 Sep; 46(3):307-12. PubMed ID: 26233483 [TBL] [Abstract][Full Text] [Related]
48. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Esposito S; Noviello S; Leone S; Tice A; Seibold G; Nathwani D; Scaglione F; Int J Antimicrob Agents; 2004 Nov; 24(5):473-8. PubMed ID: 15519480 [TBL] [Abstract][Full Text] [Related]
49. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Heintz BH; Halilovic J; Christensen CL Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938 [TBL] [Abstract][Full Text] [Related]
50. Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy. Tice AD J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii83-6. PubMed ID: 15150187 [TBL] [Abstract][Full Text] [Related]
51. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis. Graham AC; Mercier RC; Achusim LE; Pai MP Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688 [TBL] [Abstract][Full Text] [Related]
52. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494 [TBL] [Abstract][Full Text] [Related]
53. Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece. Theocharis G; Rafailidis PI; Rodis D; Kontopidis I; Barbas SG; Falagas ME Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):2957-61. PubMed ID: 22653635 [TBL] [Abstract][Full Text] [Related]